Market World Next Generation Cancer Diagnostics Market

Next Generation Cancer Diagnostics Market Applications, Status,
Specifications and Forecasts Till 2024
“Next Generation Cancer Diagnostics Market Report Includes in-depth
analysis of Market Application, Size, Specification, Trends, Major
Manufacturers and Business Strategies by Considering Types, Market
Segmentation and Analysis.”
Industry Insights
Global Next Generation Cancer Diagnostics Market Size was worth USD 4,964.05 million in 2016 which is
anticipated to grow at a CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to the
increasing occurrence of the cancer, second most predominant disease accounting for approximately 8.8 million
deaths in 2015 is anticipated to escalate the market for these tests.
Advancements in tests enable early diagnosis and assist efficient detection of different types of tumors which
in turn is expected to promote growth over the projected period. The introduction of new products by large
bodies, merger, and acquisitions, and joint agreements such as the development of RNA-Seq Kit version by
Agilent Technologies Inc. and Agendia Inc. are the factors accountable for the estimated CAGR.
An escalation in the development of companion diagnostics in order to deliver advanced and personalized
genomic medicine is also responsible for progress in the coming years.
Furthermore, the technological advancements driving the innovation in point-of-care testing devices is
anticipated to aid in commercialization of advanced products thereby supporting revenue generation.
Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market/request-sample